Cambridge Investment Research Advisors, Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$338
+6.0%
2,790
+0.1%
0.00%
+100.0%
Q2 2023$319
-16.9%
2,788
+0.1%
0.00%
-50.0%
Q1 2023$384
+80.3%
2,785
+69.4%
0.00%
+100.0%
Q4 2022$213
-99.9%
1,644
-22.1%
0.00%0.0%
Q3 2022$233,000
-20.7%
2,111
-35.3%
0.00%0.0%
Q4 2021$294,000
-23.0%
3,265
-20.9%
0.00%
-50.0%
Q3 2021$382,000
-7.7%
4,130
-22.5%
0.00%0.0%
Q2 2021$414,000
+11.9%
5,331
+7.3%
0.00%0.0%
Q1 2021$370,000
-35.9%
4,966
+46.7%
0.00%
-33.3%
Q4 2020$577,000
+0.2%
3,386
-17.5%
0.00%
-25.0%
Q3 2020$576,000
-14.5%
4,103
-2.4%
0.00%
-20.0%
Q2 2020$674,000
+36.2%
4,202
-17.0%
0.01%0.0%
Q1 2020$495,000
-17.8%
5,065
+8.6%
0.01%0.0%
Q4 2019$602,000
+74.5%
4,665
+1.9%
0.01%
+66.7%
Q3 2019$345,000
-51.3%
4,579
-1.8%
0.00%
-57.1%
Q2 2019$708,000
+27.3%
4,6610.0%0.01%
+40.0%
Q1 2019$556,000
+22.2%
4,661
+11.9%
0.01%0.0%
Q4 2018$455,000
-56.0%
4,166
-34.8%
0.01%
-50.0%
Q3 2018$1,033,000
+105.8%
6,393
+68.4%
0.01%
+100.0%
Q2 2018$502,000
-35.8%
3,797
-64.0%
0.01%
-44.4%
Q1 2018$782,000
+203.1%
10,551
+127.4%
0.01%
+200.0%
Q4 2017$258,000
+0.8%
4,639
-17.9%
0.00%0.0%
Q3 2017$256,0005,6500.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders